Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of PBK_M2301 in Healthy Volunteers
NCT07161180Phase 1Recruiting
- Sponsor
- Pharmbio Korea Inc.
- Start
- Aug 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levodropropizine and pelargonium sidoides extract in cough and acute bronchitis (2 arms), sponsored by Pharmbio Korea Inc. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve to Last Quantifiable Concentration. Started Aug 2025; status: recruiting.
02
Drugs
levodropropizinepelargonium sidoides extract
03
Conditions
coughacute bronchitis
Beyond the preview
Go deeper on NCT07161180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07161180.